MedTrace Logo

Drug-drug Interactions With Anti-tuberculous Drugs

NCT06381375 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-08-22

No results posted yet for this study

Summary

This study aims to assess the prevalence and the outcome of prescribing drugs known to have major drug-drug interactions with anti-tuberculous drugs among Kasr Alainy tuberculous patients.

Conditions

  • Drug-drug Interaction

Interventions

OTHER

Anti Tuberculosis Drug

1. Estimate the prevalence of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients. 2. Assess the outcome of prescribing drugs known to have major drug-drug interaction(s) with anti-tuberculous drugs among Kasr Alainy tuberculous patients (response to treatment and the prevalence of life-threatening events).

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Soha Aly Elmorsy · Cairo University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-30
Primary Completion
2024-12-01
Completion
2025-02-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06381375 on ClinicalTrials.gov